Viewing nowLami Tablet (Terbinafine Hydrochloride)
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Hubist Pharmaceutical Co., Ltd.

MFDS item code 201404590 · Approved 2014.10.06 · Insurance code 628800290
Treatment of onychomycosis, skin fungal infections (including athlete’s foot and jock itch), and tinea capitis in children
This medication is used for the treatment of dermatophyte infections such as tinea pedis, tinea corporis, and tinea cruris in adults, and is effective for tinea capitis in children. In other words, this medicine is used to improve fungal infections that occur in the skin and nails.
Administer terbinafine 125 mg twice daily or 250 mg once daily. The treatment duration according to the condition is as follows: 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Usually administer for 6 weeks~3 months. For infections of the fingernails or relatively small toenails, the treatment duration may be shortened to 3 months or less. A treatment duration of 3 months is usually sufficient for toenail infections, although some patients may require 6 months or longer. Treatment may need to be prolonged in patients with slow nail growth. For patients with creatinine clearance below 50 mL per minute, reduce the daily dose by 1/2.
Administer to children aged 2 years and older. Administration is not recommended for children under 2 years of age because there is no experience with its use in this age group. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of infection, treatment should be administered regularly for the appropriate prescribed duration. 1) Body weight under 20 kg (under 5 years): Administer 62.5 mg once daily. Due to limited experience with treatment, the decision to administer should be based on consideration of the benefits and risks of treatment. 2) Body weight 20~40 kg (5~12 years): Administer 125 mg once daily. 3) Body weight over 40 kg (over 12 years): Administer 250 mg once daily. In younger patients, the treatment duration may be shortened to 3 months or less.
This medication should preferably not be used in patients with chronic or active liver disease. It is essential to confirm any liver disease before taking this medicine, and liver function tests should be conducted regularly before and during treatment. If symptoms of liver dysfunction occur, such as nausea, loss of appetite, fatigue, vomiting, pain in the upper right abdomen, jaundice, dark urine, or diarrhea, notify your doctor immediately and discontinue the medication. Furthermore, this medication can cause serious liver damage, such as liver failure, so if signs of liver damage appear, immediately stop taking it and undergo liver function tests. Patients who are allergic to this medication, have blood disorders, severe renal failure, are under 2 years of age, are breastfeeding, or have lactose intolerance should not take it. Patients with compromised kidney function, elderly individuals, underweight children, patients with psoriasis or systemic lupus erythematosus should use this medication with caution, and if serious skin reactions such as rashes occur, discontinue use immediately. Various side effects may occur while taking this medication, so if symptoms such as skin rashes, muscle pain, headaches, digestive disorders, mental changes, or visual impairments occur, consult with your healthcare provider. Caution should be exercised while driving or operating machinery as dizziness may occur, and interactions with other medications may take place, so it is important to inform your doctor or pharmacist of all other medications being taken. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of taking this medication, and if breastfeeding, should discontinue nursing while on this medicine. Children and the elderly should take this medication with special care, and in case of overdose, symptoms such as headaches, nausea, abdominal pain, and dizziness may occur, so immediate medical attention should be sought. This medication should be stored out of reach of children and should be kept in a tightly sealed container away from direct sunlight at room temperature.
Liver and biliary insufficiency, hepatitis, biliary stasis, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, malaise, elevation of γ-GTP, elevation of AST/ALT, elevation of LDH, elevation of ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, petechiae, leukopenia, anemia, rash, itching, photosensitivity reaction, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, blistering dermatitis, psoriasiform rash, exacerbation of psoriasis, hair loss, musculoskeletal reaction, arthralgia, myalgia, weakness, elevation of CPK, rhabdomyolysis, hypotension, dyspnea, chest tightness, urticaria, erythema, facial swelling, lymphangiectasia, abdominal distension, decreased appetite, dyspepsia, nausea, mild abdominal pain, diarrhea, discomfort in the upper abdomen, thirst, vomiting, glossitis, depression, anxiety, headache, taste disturbance, dizziness, drowsiness, paresthesia, sensory loss, decreased attention, insomnia, elevation of BUN, pollakiuria, visual impairment, tinnitus, anaphylactoid reaction, angioedema, systemic lupus erythematosus, increase in serum total cholesterol, elevation of triglycerides, malaise, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, decreased vision, hearing impairment, auditory dysfunction, vasculitis, permanent anosmia, anosmia, hyposmia, drug eruption accompanied by eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, influenza-like illness, increased blood creatine phosphokinase, headache, nausea, upper abdominal pain, dizziness
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to avoid exposure to air or moisture. Additionally, it is best stored at room temperature between 1°C and 30°C, avoiding extremely hot or cold environments.
White round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTerbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Hubist Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.